Hemispherx preclinical data

In an insulin-like growth factor binding protein 2 ( IGFBP2) transgenic mouse model of breast cancer, IGFBP2 antigens plus adjuvant Ampligen significantly inhibited tumor growth by 60% vs. 23% for mi...